Breaking News Instant updates and real-time market news.

BAX

Baxter

$75.62

0.48 (0.64%)

, AKRX

Akorn

$3.73

0.03 (0.81%)

15:23
03/12/19
03/12
15:23
03/12/19
15:23

Baxter tells Bloomberg not in talks with Akorn, has no plans to submit offer

A spokeswoman for Baxter (BAX) told Bloomberg that the company is not in advanced talks with Akorn (AKRX) and has no plans to submit an offer to buy Akorn, refuting an earlier report from Intereconomia.

BAX

Baxter

$75.62

0.48 (0.64%)

AKRX

Akorn

$3.73

0.03 (0.81%)

  • 12

    Mar

  • 01

    May

BAX Baxter
$75.62

0.48 (0.64%)

01/02/19
SBSH
01/02/19
NO CHANGE
SBSH
Citi makes four rating changes in Medical Devices, 'warning up' to J&J
Citi analyst Amit Hazan issued his 2019 preview for Medical Devices, which included four rating changes. The analyst upgraded both Zimmer Biomet (ZBH) and Baxter International (BAX) to Buy from Neutral, downgraded Medtronic (MDT) to Neutral from Buy and downgraded Abbott Laboratories (ABT) to Sell from Neutral. He also kept Buy ratings on Intuitive Surgical (ISRG) and Boston Scientific (BSX), but adds he's "relatively more cautious." Further, Hazan kept a Sell rating on Edwards Lifesciences (EW) and says he's "warming up" to Neutral-rated Johnson & Johnson (JNJ). The analyst expects "fairly stable" fundamentals for the group in 2019, with "modest slowdowns" in organic sales and earnings growth.
02/01/19
PIPR
02/01/19
NO CHANGE
Target $80
PIPR
Overweight
Baxter price target raised to $80 from $72 at Piper Jaffray
Piper Jaffray analyst Matt O'Brien raised his price target for Baxter International to $80 after the company's Q4 results topped expectations on both the top- and bottom-lines. The primary drivers of the revenue beat in the quarter were the company's Renal Care, Pharma, Advanced Surgery and Acute Therapies, O'Brien tells investors in a research note. Further, he believes Baxter's domestic Medication Delivery and Nutrition businesses stabilized during the quarter "with progress made towards restoring demand to pre-hurricane levels." The analyst remains constructive on the stock and reiterates an Overweight rating.
02/01/19
LEHM
02/01/19
UPGRADE
Target $72
LEHM
Equal Weight
Baxter upgraded to Equal Weight from Underweight at Barclays
Barclays analyst Kristen Stewart upgraded Baxter International to Equal Weight and raised her price target for the shares to $72 from $67. Over the past three months, expectations for the company have been reset, making a neutral rating more appropriate, Stewart tells investors in a research note.
02/01/19
02/01/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. United Technologies (UTX) upgraded to Conviction Buy from Buy at Goldman Sachs. 2. Eldorado Gold (EGO) upgraded to Outperform from Sector Perform at National Bank and to Outperform from Market Perform at BMO Capital. 3. Baxter (BAX) upgraded to Equal Weight from Underweight at Barclays with analyst Kristen Stewart saying over the past three months, expectations for the company have been reset, making a neutral rating more appropriate. The analyst also raised her price target for the shares to $72 from $67. 4. Cooper Companies (COO) upgraded to Overweight from Equal Weight at Stephens with analyst Chris Cooley saying he believes that the company is positioned to boost its earnings guidance, citing a stronger growth of its single-use daily SiH contact lens sales, above-forecast Paragard sales, and more modest FX-related headwinds than previously anticipated. 5. Allegiant Travel (ALGT) upgraded to Outperform from In-Line at Imperial Capital with analyst Michael Derchin saying he views the shares as attractive after the company's fiscal 2019 earnings outlook came in well ahead of his expectations. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
AKRX Akorn
$3.73

0.03 (0.81%)

11/27/18
PIPR
11/27/18
NO CHANGE
Target $9
PIPR
Overweight
Akorn approval an 'encouraging development,' says Piper Jaffray
Piper Jaffray analyst David Amsellem views Akorn's (AKRX) approval of its generic of Voltaren Gel as an "encouraging development." The news demonstrates that the company can execute on the approval of products on the more technically challenging end of the generics spectrum, Amsellem tells investors in a research note. The analyst believes Akorn is well positioned for "significant EBITDA recovery" over the next two years. He sees a "high likelihood" that the company in 2018 will have worked through the bulk of the erosion of key generics due to competition and a "relatively high" probability of meaningful cost reductions if it loses its appeal in its case against Fresenius (FSNUY). Amsellem reiterates an Overweight rating on Akorn with a $9 price target.
12/07/18
CHLM
12/07/18
NO CHANGE
Target $11
CHLM
Buy
Craig-Hallum maintains Buy rating, $11 target on Akorn after Fresenius ruling
Craig-Hallum analyst Matt Hewitt said the Delaware Supreme Court ruling in favor of Fresenius (FSNUY) ends any hopes that a merger with Akorn (AKRX) will still occur, which may be a disappointment to some investors. However, it has been his view since the first ruling was announced that Akorn should be valued on a standalone basis. Akorn currently has a large pipeline of higher margin generics and the company's low-cost manufacturing facility in India has been idled due to the terms of the Fresenius agreement, but is likely to be brought online sometime in FY19 or FY20, Hewitt tells investors. He keeps a Buy rating and $11 price target on Akorn shares, which are down $1.34, or 24%, to $4.25 in afternoon trading.
12/10/18
PIPR
12/10/18
NO CHANGE
Target $9
PIPR
Overweight
Piper does not view Akorn as 'major fixer-upper,' keeps $9 target
Piper Jaffray analyst David Amsellem says he would not view Akorn (AKRX) as a "major fixer-upper" now that it is planning to move forward as a stand-alone company. Much of the pressure on EBITDA in recent years was a function of limited-competition products with brand-like margins, Amsellem tells investors in a research note. Further, the rest of Akorn's product portfolio appears to be stable, says the analyst. In addition, "high-quality" abbreviated new drug application approvals have been happening, "and that matters," argues Amsellem. He keeps an Overweight rating on Akorn with a $9 price target.
03/11/19
JMPS
03/11/19
NO CHANGE
JMPS
Market Perform
Akorn is currently fairly valued, says JMP Securities
Akorn's Q4 results were negatively impacted by manufacturing issues, and the company is dedicating 2019 to remediating the issues, JMP Securities analyst Donald Ellis tells investors in a post-earnings research note. The company also experienced increasing competition for multiple products and lower overall prices impacting revenues, the analyst adds. Ellis believes Akorn's new management team is equipped to expedite its manufacturing remediation and re-start new drug submissions and approvals. However, he finds the stock currently fairly valued and maintains a Market Perform rating on the name.

TODAY'S FREE FLY STORIES

YEXT

Yext

$23.00

0.33 (1.46%)

22:43
03/18/19
03/18
22:43
03/18/19
22:43
Syndicate
Yext 6.1M share Spot Secondary priced at $21.50 »

Goldman Sachs is acting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

WU

Western Union

$18.17

-0.2 (-1.09%)

22:42
03/18/19
03/18
22:42
03/18/19
22:42
Hot Stocks
Western Union to partner with emerging-market moble network Thunes »

Western Union has teamed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYL

Mylan

$28.17

0.09 (0.32%)

22:40
03/18/19
03/18
22:40
03/18/19
22:40
Hot Stocks
Mylan conducts voluntary recall of Levoleucovorin Injection »

Mylan Institutional LLC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TYHT

Shineco

$0.67

0.0003 (0.04%)

20:43
03/18/19
03/18
20:43
03/18/19
20:43
Recommendations
Shineco analyst commentary  »

Shineco establishing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATVI

Activision Blizzard

$44.97

0.33 (0.74%)

20:31
03/18/19
03/18
20:31
03/18/19
20:31
Hot Stocks
Activision Blizzard unveils Call of Duty: Mobile edition »

Activision, in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$372.10

-6.795 (-1.79%)

20:28
03/18/19
03/18
20:28
03/18/19
20:28
Hot Stocks
Boeing CEO says 'work progressing thoroughly' to understand cause for 737 crash »

In a letter, Boeing CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 28

    May

GPX

GP Strategies

$12.57

-1.745 (-12.19%)

20:25
03/18/19
03/18
20:25
03/18/19
20:25
Recommendations
GP Strategies analyst commentary at Barrington »

GP Strategies organic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

MIK

Michaels

$11.79

0.11 (0.94%)

, DSW

DSW

$25.30

-0.09 (-0.35%)

20:25
03/18/19
03/18
20:25
03/18/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

MIK

Michaels

$11.79

0.11 (0.94%)

DSW

DSW

$25.30

-0.09 (-0.35%)

HDS

HD Supply

$43.09

0.09 (0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 19

    Mar

  • 19

    Mar

  • 25

    Mar

  • 26

    Mar

  • 27

    Mar

NVDA

Nvidia

$168.91

-0.99 (-0.58%)

, AMZN

Amazon.com

$1,742.00

29.29 (1.71%)

20:19
03/18/19
03/18
20:19
03/18/19
20:19
Hot Stocks
Nvidia to partner with Amazon on bringing AI to connected devices »

NVIDIA (NVDA) announced a…

NVDA

Nvidia

$168.91

-0.99 (-0.58%)

AMZN

Amazon.com

$1,742.00

29.29 (1.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 19

    Mar

  • 20

    Mar

  • 26

    Mar

  • 04

    Apr

MEOH

Methanex

$57.22

1.68 (3.02%)

19:57
03/18/19
03/18
19:57
03/18/19
19:57
Hot Stocks
Methanex confirms M&G Investment letter, urges shareholders take no action »

Methanex confirms that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HDS

HD Supply

$43.09

0.09 (0.21%)

19:55
03/18/19
03/18
19:55
03/18/19
19:55
Earnings
HD Supply sees FY19 EPS $3.52-$3.81, consensus $3.64 »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 27

    Mar

HDS

HD Supply

$43.09

0.09 (0.21%)

19:53
03/18/19
03/18
19:53
03/18/19
19:53
Earnings
HD Supply sees Q1 EPS 75c-84c, consensus 85c »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 27

    Mar

HDS

HD Supply

$43.09

0.09 (0.21%)

19:52
03/18/19
03/18
19:52
03/18/19
19:52
Earnings
HD Supply reports Q4 adjusted EPS 70c, consensus 67c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 27

    Mar

CASA

Casa Systems

$8.89

-0.06 (-0.67%)

19:47
03/18/19
03/18
19:47
03/18/19
19:47
Initiation
Casa Systems initiated at DA Davidson »

Casa Systems initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCI

Crown Castle

$124.67

-0.41 (-0.33%)

19:46
03/18/19
03/18
19:46
03/18/19
19:46
Downgrade
Crown Castle rating change at Deutsche Bank »

Crown Castle downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARPO

Aerpio Pharmaceuticals

$1.22

-2.915 (-70.58%)

19:39
03/18/19
03/18
19:39
03/18/19
19:39
Downgrade
Aerpio Pharmaceuticals rating change at Guggenheim »

Aerpio Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

LIVX

LiveXLive Media

$6.30

0.19 (3.11%)

19:37
03/18/19
03/18
19:37
03/18/19
19:37
Initiation
LiveXLive Media initiated at Maxim »

LiveXLive Media initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 30

    Apr

  • 01

    May

AKBA

Akebia

$8.19

0.01 (0.12%)

19:31
03/18/19
03/18
19:31
03/18/19
19:31
Recommendations
Akebia analyst commentary at Piper Jaffray »

Akebia investors should…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

VALE

Vale

$13.28

0.11 (0.84%)

19:18
03/18/19
03/18
19:18
03/18/19
19:18
Periodicals
Vale to resume activities at port after court injunction, Reuters reports »

Vale said Friday that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

TROX

Tronox

$12.09

0.2 (1.68%)

19:00
03/18/19
03/18
19:00
03/18/19
19:00
Hot Stocks
Tronox to present National Titanium Dioxide deal to FTC »

Tronox confirmed that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HYMTF

Hyundai Motor

$0.00

(0.00%)

, HYMLF

Hyundai Motor Co

$0.00

(0.00%)

18:58
03/18/19
03/18
18:58
03/18/19
18:58
Hot Stocks
Connecticut AG announces probe into Hyundai, Kia fires »

Connecticut Attorney…

HYMTF

Hyundai Motor

$0.00

(0.00%)

HYMLF

Hyundai Motor Co

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYNH

Syneos Health

$47.42

0.49 (1.04%)

, TLRY

Tilray

$72.15

-0.38 (-0.52%)

18:54
03/18/19
03/18
18:54
03/18/19
18:54
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: …

SYNH

Syneos Health

$47.42

0.49 (1.04%)

TLRY

Tilray

$72.15

-0.38 (-0.52%)

EOLS

Evolus

$23.80

-1.02 (-4.11%)

AMRS

Amyris

$3.83

-0.1 (-2.54%)

FOE

Ferro

$18.88

0.125 (0.67%)

REV

Revlon

$19.39

0.42 (2.21%)

AKBA

Akebia

$8.19

0.01 (0.12%)

TORC

ResTORbio

$8.97

0.27 (3.10%)

TACO

Del Taco

$10.60

0.47 (4.64%)

HQY

HealthEquity

$82.86

0.76 (0.93%)

CVTI

Covenant Transportation

$21.43

-0.4 (-1.83%)

YEXT

Yext

$23.00

0.33 (1.46%)

WAGE

WageWorks

$39.59

1.875 (4.97%)

TWO

Two Harbors

$14.26

0.07 (0.49%)

AGS

PlayAGS

$25.65

-0.89 (-3.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 18

    Mar

  • 18

    Mar

  • 18

    Mar

  • 18

    Mar

  • 18

    Mar

  • 18

    Mar

  • 18

    Mar

  • 18

    Mar

  • 19

    Mar

  • 19

    Mar

  • 21

    Mar

  • 17

    Apr

  • 16

    May

  • 19

    Mar

  • 19

    Mar

  • 19

    Mar

  • 20

    Mar

AAPL

Apple

$188.03

1.83 (0.98%)

18:52
03/18/19
03/18
18:52
03/18/19
18:52
Periodicals
Apple stops iOS 12.1.3 code signing after iOS 12.1.4 launch, AppleInsider says »

Apple has stopped signing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WP

Worldpay

$108.52

9.8 (9.93%)

, FIS

FIS

$108.14

-0.73 (-0.67%)

18:41
03/18/19
03/18
18:41
03/18/19
18:41
Downgrade
Worldpay, FIS rating change at BMO Capital »

Worldpay downgraded to…

WP

Worldpay

$108.52

9.8 (9.93%)

FIS

FIS

$108.14

-0.73 (-0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 18

    Mar

  • 19

    Mar

  • 26

    Mar

  • 27

    Mar

  • 28

    Mar

  • 04

    Apr

ERIC

Ericsson

$9.56

-0.075 (-0.78%)

18:32
03/18/19
03/18
18:32
03/18/19
18:32
Hot Stocks
Ericsson selected by TDC to roll out commercial 5G in Denmark »

Ericsson has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.